Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Training to improve brain control and reduce excess weight

Official title: Inhibitory Control Training and Theta Burst Transcranial Magnetic Stimulation (iTBS) for Treating People With Excess Weight: Behavioral and Brain Changes (InhibE).

Run by Universidad de Granada · NCT06668077 · Data updated 2026-11-12

This study is testing whether a new brain training method combined with a special type of brain stimulation can help people with excess weight make healthier choices and improve their overall well-being.

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment141 (estimated)
SponsorUniversidad de Granada
Academic / other
Locations1 site (Granada)
StatusRecruiting
StartedNovember 30, 2024
Main results expectedNovember 30, 2024
Study endsDecember 2026
Registry record updatedFebruary 14, 2025
Trial IDNCT06668077 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 to 60 with a BMI between 25 and 39.9 who are proficient in Spanish.

Probably not a fit

Patients with severe psychological disorders, eating disorders, or contraindications for iTBS or fMRI will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of intermittent theta burst transcranial magnetic stimulation (iTBS) on the dorsolateral prefrontal cortex (DLPFC) combined with inhibitory control training to address issues related to excess weight. Participants will be randomly assigned to receive either active iTBS with training, active iTBS alone, or a control condition. The study aims to evaluate changes in body mass index (BMI), cravings, cognitive functions, and emotional well-being, as well as alterations in brain connectivity and activation. By targeting impulsivity and decision-making deficits, the intervention seeks to promote healthier behaviors and improve overall health outcomes.

Why it matters

Potential benefit: If successful, this intervention could lead to significant reductions in weight and improvements in cognitive and emotional health for individuals struggling with excess weight.

How similar studies have gone: While the combination of iTBS and cognitive training is a novel approach, similar studies have shown promise in using neuromodulation techniques for behavioral and cognitive improvements.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* BMI between 25 and 39.9
* Age between 18 and 60 years
* Proficiency in the Spanish language
* Right lateral dominance to avoid differential effects due to cortical hemispheric specialization

Exclusion Criteria:

* Traumatic, digestive, metabolic or systemic disorders that affect the central nervous system, autonomic or endocrine
* Severe psychopathological disorders and suicidal ideation or treatment for depression
* Eating disorders
* Contraindication for performing fMRI (pregnancy, metal implants, etc.) or iTBS (tinnitus, dizziness, surgical interventions, diseases or drugs that affect the CNS, etc.)

Where it's running

  • Mind, Brain and Behavior Research Center at University of Granada (CIMCYCUGR)
    Granada, Spain
    Recruiting

Study contacts

  • Principal investigator: Raquel Vilar López, Ph.D. — Universidad de Granada
  • Study coordinator: Raquel Vilar López, Ph.D.
  • Email: rvilar@ugr.es
  • Phone: +34699407282

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.